Research has identified c-Myc, a key oncogenic transcription factor regulated by p300/CBP-mediated high-density of H3K27Ac at super enhancer regions, as being associated with AML progression and drug resistance [57]. This evidence concerns the gene EP300 and acute myeloid leukemia.